NanoViricides Announces That Clinical Trials Of A Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

NanoViricides $NNVC is a drug development company working on a novel nanomedical treatment. It recently updated the world on the status of its long-awaited and now active trials into its lead drug candidate, NV-CoV-2